✦ LIBER ✦

A prospective study of lymphocyte subpopulations and regulatory T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis

✍ Scribed by Berta Soldevila; Núria Alonso; Maria J. Martínez-Arconada; Maria L. Granada; Diogo Baía; Virginia Vallejos; Manuel Fraile; Rosa M. Morillas; Ramon Planas; Ricardo Pujol-Borrell; Eva M. Martínez-Cáceres; Anna M. Sanmartí

Book ID: 108704974
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 497 KB
Volume: 75
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2011.04112.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory T cells contribute to the imp

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection

✍ Jeroen N. Stoop; Renate G. van der Molen; Carla C. Baan; Luc J. W. van der Laan; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to HBV. Regulatory T cells (T(reg)) can suppress the function of effector T cells and may thus be key players in this impaired immune response. Changes in the functionality or number of T(reg) could explain the decr

A prospective study of T- and B-lymphocy

A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment

✍ B. Soldevila; N. Alonso; M. J. Martínez-Arconada; R. M. Morillas; R. Planas; A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Level, phenotype and activation status o

Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus

✍ N. I. Rallón; M. López; V. Soriano; J. García-Samaniego; M. Romero; P. Labarga; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

A randomised controlled trial of recombi

A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection

✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for

Daily dose of interferon alpha-2b and ri

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

✍ GianPiero Benetti; Mauro Borzio; Giuliano Ramella; Giorgio Bellati; Silvia Fargi 📂 Article 📅 2006 🏛 Springer Milan 🌐 English ⚖ 98 KB

Could a loss of memory T cells limit res

Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-α and ribavirin therapy?

✍ S. Lee; T. Hammond; M. W. Watson; J. P. Flexman; W. Cheng; S. Fernandez; P. Pric 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB